Évaluation des complications majeures de la surrénalectomie laparoscopique : à propos de 469 cas
A. Gryn(Hôpital Rangueil), É. Huyghe(Université Toulouse III - Paul Sabatier), Delphine Vezzosi(Université Toulouse III - Paul Sabatier), Bernard Malavaud(Université Toulouse III - Paul Sabatier), Béatrice Duly‐Bouhanick(Université d'Angers), Jean‐Baptiste Beauval, M. Roumiguié(Institut universitaire du cancer de Toulouse Oncopole), M. Thoulouzan(Hôpital Rangueil), J. Gas(Hôpital Rangueil), X. Gamé(Metabolism and Renal Physiology), B Chamontin(Inserm), Jacques Amar(Hôpital Rangueil), G. Crenn(Hôpital Rangueil), M. Soulié(Hôpital Rangueil), A. Bennet, P. Rischmann(Hospices Civils de Lyon), Philippe Caron(Hôpital Larrey)
Cited by 1
Related Papers
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome
|New England Journal of Medicine|2014|434
Ketoconazole in Cushing's Disease: Is It Worth a Try?
|The Journal of Clinical Endocrinology & Metabolism|2014|288
Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity
|Nature Communications|2016|287